Browsing Tag
Viyash Lifesciences
1 post
SeQuent Scientific (NSE: SEQUENT) and Viyash Lifesciences merger gets NCLT approval, setting stage for India’s largest animal health platform
With over ₹16,462 million in H1 FY26 revenue and significant margin expansion, the newly combined entity is positioning itself as a top-tier global player in the animal health and pharmaceutical contract development space